Skip to main content

Table 1 Demographic, clinical and pathological characteristics of the two groups of the HCC patients

From: Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population

Parameter

Recurrence group

(n = 29)

Non-recurrence group

(n = 44)

P value

Recipient age

48(21–67)

49.5(33–62)

0.811

  ≥ 50

13(44.8%)

22(50.0%)

 

 <50

16(55.2%)

22(50.0%)

 

Recipient gender

  

1.000

 Male

25(86.2%)

39(88.6%)

 

 female

4(13.8%)

5(11.4%)

 

Hepatitis B

  

0.207

 Yes

25(86.2)%)

42(95.5%)

 

 No

4(13.8%)

2(4.5%)

 

Cirrhosis

  

0.154

 Yes

20(69.0%)

37(84.1%)

 

 No

9(31.0%)

7(15.9%)

 

Milan criteria

  

0.000

 In

2(6.9%)

29(65.9%)

 

 Out

27(93.1%)

15(34.1%)

 

TNM stage

  

0.000

 1–2

12(41.4%)

38(86.4%)

 

 3–4

17(58.6%)

6(13.6%)

 

Tumor size (cm)

  

0.000

  > 5

26(89.7%)

18(40.9%)

 

  ≤ 5

3(10.3%)

26(59.1%)

 

Multinodular type

  

0.219

 YES

15(51.7%)

30(68.2%)

 

 NO

14(48.3%)

14(31.8%)

 

Pre-OLT serum AFP level

  

0.165

  ≤ 400 (ng/ml)

19(65.5%)

36(81.8%)

 

  > 400 (ng/ml)

10(34.5%)

8(18.2%)

 

Microvascular invasion

  

0.000

 Yes

14(48.3%)

2(4.5%)

 

 No

15(51.7%)

42(95.5%)

 

Macrovascular invasion

  

0.425

 YES

4(57.1%)

3(42.9%)

 

 NO

25(37.9%)

41(62.1%)

 
  1. Abbreviations
  2. HCC hepatocellular carcinoma, TNM tumor node metastasis, AFP alpha-fetoprotein, OLT orthotopic liver transplantation